Somaxon (SOMX) Closes 9.4M Direct Offering; Sees Gross Proceeds of $3M

Article Stock Quotes (1) Comments (0)

Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), has completed its previously announced registered direct offering of approximately 9.4 million shares of its common stock and warrants to purchase up to approximately 4.7 million shares of its common stock to institutional investors. Aggregate gross proceeds to the company were approximately $3.0 million, before deducting anticipated placement agent fees and expenses of approximately $0.3 million. The warrants will have an initial exercise price of $0.46 per share, will be exercisable commencing six months and one day from the date of issuance and will expire on the fifth anniversary of the initial exercise date. Roth Capital Partners acted as sole placement agent for the offering.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• BioLineRx (BLRX) Enters $20M ATM Offering w/ Stifel
• Triple-S (GTS) Prices 5.4M Common Secondary Offering
• DDR Corp (DDR) Prices Upsized 34M Common Stock Offeing

Create E-mail Alert Related Categories

Corporate News, Equity Offerings

Related Entities

Roth Capital

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?